Cross Herb
- SEC CIK
- 0001230721
No open-market purchases or sales filed in the past year.
Current role at each company
- JSPR Jasper Therapeutics, Inc.Chief Financial Officeras of Jan 5, 2026
- APGN Apexigen, Inc.Directoras of Aug 25, 2023
- BCEL Atreca, Inc.Chief Financial Officeras of Aug 4, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Cross Herb as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BCEL Atreca, Inc.
Chief Financial Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 4, 2023 (view filing) | Aug 2 | 2 days | Cross HerbChief Financial Officer | SSaleClass A Common Stock | −5.49K | $0.95 | −$5.21K | −7.0%72.8K after | |
| Sep 20, 2022 (view filing) | Sep 2 | 18 daysLate | Cross HerbChief Financial Officer | SSaleClass A Common Stock | −7.65K | $1.78 | −$13.6K | −18.1%34.6K after |